• Publications
  • Influence
Aging of mesenchymal stem cell in vitro
BackgroundA hot new topic in medical treatment is the use of mesenchymal stem cells (MSC) in therapy. The low frequency of this subpopulation of stem cells in bone marrow (BM) necessitates their inExpand
  • 675
  • 21
Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis.
BACKGROUND The standard treatment for decompensated liver cirrhosis is liver transplantation. However, it has several limitations. Recent animal studies suggest that bone marrow stem cellExpand
  • 273
  • 13
  • PDF
Treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and/or chemotherapy.
INTRODUCTION Arsenic trioxide is effective and approved for treatment of relapsed or refractory acute promyelocytic leukemia (APL) cases resistant to all-trans retinoic acid (ATRA), but its effect onExpand
  • 200
  • 12
Randomized placebo‐controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis
There has been great interest in recent years to take advantage of bone marrow stem cells to treat cirrhosis. Our uncontrolled trial showed promising results for bone marrow mesenchymal stem cellExpand
  • 88
  • 7
Autologous in vitro expanded mesenchymal stem cell therapy for human old myocardial infarction.
BACKGROUND Stem cell transplantation after myocardial infarction has been claimed to restore cardiac function. Mesenchymal stem cells attract a lot of attention because of the feasibility of in vivoExpand
  • 82
  • 4
  • PDF
The effect of zinc sulfate in the prevention of high‐dose chemotherapy‐induced mucositis: a double‐blind, randomized, placebo‐controlled study
The purpose of this study was to evaluate the effect of oral zinc sulfate in the prevention of chemotherapy‐induced mucositis in patients undergoing hematopoietic stem‐cell transplantation (HSCT).Expand
  • 26
  • 4
Evaluation of nutritional status in patients undergoing hematopoietic SCT
The aims of this study were to establish the nutritional status of patients during hematopoietic SCT (HSCT) and to determine if body mass index (BMI) is a valid indicator of nutritional status inExpand
  • 55
  • 3
Frequency of BCR-ABL fusion transcripts in Iranian patients with chronic myeloid leukemia.
BACKGROUND A specific chromosomal abnormality, the Philadelphia chromosome, is present in 90 - 95% of patients with chronic myeloid leukemia. The aberration results from a reciprocal translocation ofExpand
  • 51
  • 3
  • PDF
Effects of chimerism on graft-versus-host disease, disease recurrence, and survival after HLA-identical marrow transplantation in Iran.
BACKGROUND The coexistence of recipient's and donor's hematopoietic systems after allogeneic marrow transplantation is called mixed chimerism. OBJECTIVE The objective of this study was to evaluateExpand
  • 8
  • 3
  • PDF
Detection of nucleophosmin and FMS-like tyrosine kinase-3 gene mutations in acute myeloid leukemia
Background and Objectives : Nucleophosmin gene mutations are frequently reported in acute myeloid leukemia (AML) patients with normal karyotype, which is also frequently associated with internalExpand
  • 18
  • 3